-transparent.png){kind=logo}
Focal therapy (FT) has recently gained popularity for the treatment of localized prostate cancer (PCa). FT achieves cancer control by targeting the lesions or the regions of the cancer and avoids damage to the surrounding tissues thus minimizing side effects which are common to the radical treatment, such as urinary continence and sexual function, and bowel-related side effects. Various ablative methods are used to deliver energy to the cancerous tissue. We review the different modalities of treatment and the current state of FT for PCa.
| UI | MeSH Term | Description | Entries |
|---|
Related Publications
Shrikanth Atluri, and
Ali Mouzannar, and
Vivek Venkatramani, and
Dipen J Parekh, and
Bruno Nahar
June 2015,
Prostate international,
Shrikanth Atluri, and
Ali Mouzannar, and
Vivek Venkatramani, and
Dipen J Parekh, and
Bruno Nahar
January 2018,
Reviews in urology,
Shrikanth Atluri, and
Ali Mouzannar, and
Vivek Venkatramani, and
Dipen J Parekh, and
Bruno Nahar
January 2012,
Urologic oncology,
Shrikanth Atluri, and
Ali Mouzannar, and
Vivek Venkatramani, and
Dipen J Parekh, and
Bruno Nahar
October 2011,
Archivos espanoles de urologia,
Shrikanth Atluri, and
Ali Mouzannar, and
Vivek Venkatramani, and
Dipen J Parekh, and
Bruno Nahar
September 2015,
Minerva urologica e nefrologica = The Italian journal of urology and nephrology,
Shrikanth Atluri, and
Ali Mouzannar, and
Vivek Venkatramani, and
Dipen J Parekh, and
Bruno Nahar
June 2015,
Current urology reports,
Shrikanth Atluri, and
Ali Mouzannar, and
Vivek Venkatramani, and
Dipen J Parekh, and
Bruno Nahar
December 1995,
The Prostate,
Shrikanth Atluri, and
Ali Mouzannar, and
Vivek Venkatramani, and
Dipen J Parekh, and
Bruno Nahar
November 2022,
International journal of urology : official journal of the Japanese Urological Association,
Shrikanth Atluri, and
Ali Mouzannar, and
Vivek Venkatramani, and
Dipen J Parekh, and
Bruno Nahar
October 2021,
Asian journal of urology,
Shrikanth Atluri, and
Ali Mouzannar, and
Vivek Venkatramani, and
Dipen J Parekh, and
Bruno Nahar
May 2009,
Current opinion in urology,
